Novel HBV Biomarkers-Guided NAs Withdrawal Strategy Promotes HBsAg Clearance in Asian CHB Patients: A Randomized Controlled Trial

Rong Fan(Kunming Institute of Botany), Jian Sun(Nanfang Hospital), Huiying Rao(Peking University), Yanhang Gao(Jilin University), Honglian Bai(First People's Hospital of Foshan), Xiaoguang Dou(China Medical University), Xieer Liang(Nanfang Hospital), Qing Xie(Ruijin Hospital), Hongbo Gao(Houston Methodist), Ya Xu(Harbin Medical University), Qing Guo(Hunan University), Sheng Shen(Southern Medical University), Xingyu Lu(Southern Medical University), Hong Ma(Beijing Friendship Hospital), Fang Wang(Zunyi Medical University), Chun-Xiu Zhong(Southern Medical University), Rui Deng(Southern Medical University)
Clinical Gastroenterology and Hepatology
September 14, 2025
10.1016/j.cgh.2025.09.009
Cited by 1

Related Papers

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
|New England Journal of Medicine|2022|227
MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6–p47 <sup>phox</sup> –oxidative stress pathway in neutrophils
|Gut|2016|225
Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
|PLoS Pathogens|2014|224
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles
|Journal of Hepatology|2019|209